Evotec SE
EVT.DE$1.12B
Small CapXETRABiotechnology🇺🇸North America4.8K employees
Drugs in Pipeline
3
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
EVT.DE News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
EVT 302, 10 mg
Smoking Cessation
EVT 302
Smoking Cessation
EVT 201
Sleep Initiation and Maintenance Disorders
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
EVT 302, 10 mg | Phase 2 | Smoking Cessation | - | - |
EVT 302 | Phase 2 | Smoking Cessation | - | - |
EVT 201 | Phase 2 | Sleep Initiation and Maintenance Disorders | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply